Clinical Trials
- Heart/Cardiovascular
Botox type A for the prevention of POAF in open-chest cardiac surgery
- Ages55 years - 90 years
- GenderBoth
- Heart/Cardiovascular
Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery (START)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Study of the Relay Pro® Thoracic Stent-Graft in Subjects With Traumatic Injury of the Descending Thoracic Aorta
- Ages18 years and older
- GenderBoth